左甲状腺素钠片对妊娠合并甲状腺功能减退患者      妊娠结局影响的Meta分析

• 药品评价-循证医学研究 • 上一篇下一篇

左甲状腺素钠片对妊娠合并甲状腺功能减退患者妊娠结局影响的Meta分析

李娜,杜菲菲,姚丽,丁楠楠,张彩云,张志刚

兰州大学护理学院,兰州大学护理学院,兰州大学护理学院,兰州大学护理学院,兰州大学护理学院兰州大学第一医院护理部,兰州大学护理学院兰州大学第一医院重症医学科

收稿日期:2019-06-11 修回日期:2019-07-26 出版日期:2019-08-28 发布日期:2019-08-28

Effect of Levothyroxine Sodium Tablets on Pregnancy Outcome in Patients with Pregnancy Complicated with Hypothyroidism：A Meta-analysis

li na,,,, and

School of nursing, lanzhou university,School of nursing, lanzhou university,School of nursing, lanzhou university,School of nursing, lanzhou university,,The First Hospital of Lanzhou University

Received:2019-06-11 Revised:2019-07-26 Online:2019-08-28 Published:2019-08-28

摘要/Abstract

摘要： 目的：评价左甲状腺素钠对妊娠合并甲状腺功能减退患者用药有效性及妊娠结局的影响。方法：计算机检索PubMed、The Cochrane Library 、Web of Science、EMBASE、中国生物医学文献数据库 (CBM) 、中国知网 (CNKI) 、万方数据库 (WanfangData)和维普医学数据库（VIP）辅以人工检索，检索时限均为建库至2019年4月。由2名研究者独立进行文献筛选、资料提取，采用Revman 5.3软件进行Meta分析。结果：纳入15篇文献，共计3 895例，经Meta分析结果显示：早产OR值[0.34，95%CI（0.25~0.45），P<0.001]；流产OR值为[0.33，95%CI(0.23~0.47)，P<0.001]；妊娠高血压疾病OR值为[0.43，95%CI(0.31~0.61)，P<0.001]；产后出血OR值为[0.28，95%CI(0.19~0.43)，P<0.001]；胎盘早剥OR值为[0.48，95%CI(0.24~0.96)，P<0.001]；新生儿低体重OR值为[0.27，95%CI(0.16~0.44)，P<0.001]。结论：左甲状腺素钠结合常规干预可以改善妊娠合并甲状腺功能减退患者的妊娠结局。

Abstract: Objective：To evaluate the effect of levothyroxine sodium on the efficacy and pregnancy outcome of patients with pregnancy complicated with hypothyroidism. Methods：Computer search PubMed， The Cochrane Library、Web of Science、 EMBASE、 CBM、CNKI、 Wanfang Database、 and VIP supplemented by manual search， search the time limit is built until April 2019. Two researchers independently performed literature screening and data extraction， and meta analysis was performed using Revman 5.3 software. Results：A total of 3 895 patients were included in the literature. The results of meta-analysis showed that the premature OR value was[ 0.34， 95% CI (0.25-0.45)， P<0.001]. Abortion OR value was[ 0.33， 95% CI (0.23~0.47). P<0.001]. OR value of gestational hypertension was [0.43， 95% CI (0.31~0.61)， P<0.001]. OR value of postpartum hemorrhage was [0.28， 95% CI (0.19~0.43)， P<0.001]. Placental abruption The OR value was [0.48， 95% CI (0.24~0.96)， P<0.001]， and the neonatal low body weight OR value was [0.27， 95% CI(0.16~0.44)， P<0.001]. Conclusion：Levothyroxine sodium combined with conventional intervention can improve the thyroid function and reduce the incidence of adverse pregnancy in patients with hypothyroidism.

李娜,杜菲菲,姚丽,丁楠楠,张彩云,张志刚. 左甲状腺素钠片对妊娠合并甲状腺功能减退患者妊娠结局影响的Meta分析[J]. .

li na,,,, and. Effect of Levothyroxine Sodium Tablets on Pregnancy Outcome in Patients with Pregnancy Complicated with Hypothyroidism：A Meta-analysis[J]. .

参考文献

[1]Reid SM， Middleton P， Cossich MC， et al. Interventions for clinical and subclinical hypothyroidism pre-pregnancy and during pregnancy[J]. Cochrane database of systematic reviews (Online)， 2013， 5(5)：CD007752-CD007752. [2]Glendenning P. Management of Thyroid Dysfunction during Pregnancy and Postpartum：An Endocrine Society Clinical Practice Guideline[J]. Journal of Clinical Endocrinology & Metabolism， 2012， 8(4)：2543-65. [3]Casey BM， Leveno KJ. Thyroid disease in pregnancy.[J]. Clinics in Perinatology， 2006， 34(4)：543-557. [4]Casey BM， Dashe JS， Spong CY， et al. Perinatal Significance of Isolated Maternal Hypothyroxinemia Identified in the First Half of Pregnancy[J]. Obstetrics & Gynecology， 2007， 109(5)：1129-1135. [5]Negro R， Stagnaro-Green A. Diagnosis and management of subclinical hypothyroidism in pregnancy[J]. BMJ， 2014， 349(oct06 4)：g4929-g4929. [6]Chen S， Zhou X， Zhu H， et al. Preconception TSH and pregnancy outcomes：a population-based cohort study in 184611 women[J]. Clinical Endocrinology， 2017. [7]Glendenning P. Management of Thyroid Dysfunction during Pregnancy and Postpartum：An Endocrine Society Clinical Practice Guideline[J]. Journal of Clinical Endocrinology & Metabolism， 2012， 8(4)：2543-65. [8]中华医学会内分泌学分会，中华医学会围产医学分会．妊娠和产后甲状腺疾病诊治指南( 节选一) [J]．中华全科医师杂志，2012，11(8)：556-558. [9]胡雁.循证护理学[M]. 北京：人民卫生出版社， 2012：351. [10]赵丽杰，贾政伟，缪玉梅，等.妊娠合并甲状腺功能减退患者用药安全性及对妊娠结局的影响[J]. 实用药物与临床，2015，18(12)：1462-1465. [11]翁晓春，丁文俐，郑倩，等.妊娠期甲状腺功能减退对妊娠结局的影响及药物干预效果评价[J]. 中国实用医药，2017，12(14)：114-115. [12]王丹婵，郭焕仪.优甲乐替代疗法对妊娠合并甲状腺功能减退症患者妊娠结局的影响[J]. 临床医学工程，2017，24(07)：941-942. [13]孙亚玲，辛春，郭明，等.早期综合干预联合左甲状腺素钠治疗妊娠合并甲状腺功能减退症的临床研究[J]. 安徽医药，2019，23(01)：14-18. [14]张永梅.左甲状腺素钠应用于妊娠合并亚临床甲状腺功能减退症的疗效及对妊娠结局的影响[J]. 中国民间疗法，2019，27(03)：79-80. [15]孔丽丽，周金华，黄沁.妊娠合并亚临床甲状腺功能减退症的早期治疗对妊娠结局的影响[J]. 实用妇产科杂志，2014，30(12)：937-939. [16]王丽萍，王淑，胡虹宇，等.左甲状腺素钠治疗妊娠合并甲减的效果观察[J]. 中国民康医学，2018，30(08)：30-31. [17]康燕妮.左甲状腺素钠片对妊娠期亚临床甲减患者甲状腺功能的影响[J]. 世界最新医学信息文摘，2018，18(70)：133-134. [18]王瑞玲，朱红芳，张慧. 左甲状腺素钠片治疗妊娠期甲状腺功能减退症对甲状腺功能及妊娠结局的影响 %J 疑难病杂志.2016，15(4)：398-400，404. [19]蒋达玲.左甲状腺素钠片治疗妊娠期甲状腺功能减退症的临床疗效观察[J]. 医学信息，2018，31(20)：139-141. [20]王丽娟.左旋甲状腺素钠对妊娠合并甲状腺功能减退症患者子代智力和发育的影响[J]. 深圳中西医结合杂志，2017，27(11)：97-98. [21]衣巴地古丽·库吐鲁克，玛依努·玉苏甫.左旋甲状腺素钠片对SCH患者血清Hcy与母婴结局的影响[J]. 中国妇幼保健，2018，33(17)：3886-3889. [22]Ma L， Qi H， Chai X， et al. The effects of screening and intervention of subclinical hypothyroidism on pregnancy outcomes：a prospective multicenter single-blind， randomized， controlled study of thyroid function screening test during pregnancy[J]. The Journal of Maternal-Fetal & Neonatal Medicine， 2015， 29(9)：1391-1394. [23]Maraka S， Singh Ospina NM， O"Keeffe DT， et al. Effects of Levothyroxine Therapy on Pregnancy Outcomes in Women with Subclinical Hypothyroidism[J]. Thyroid， 2016：thy.2016.0014. [24]Nazarpour S， Ramezani Tehrani F， Simbar M， et al. Effects of Levothyroxine on Pregnant Women With Subclinical Hypothyroidism， Negative for Thyroid Peroxidase Antibodies[J]. The Journal of Clinical Endocrinology & Metabolism， 2018， 103(3)：926-935. [25]Brown S . Miscarriage and Its Associations[J]. Seminars in Reproductive Medicine， 2008， 26(5)：391-400. [26]Wang S， Teng WP， Li JX， et al. Effects of maternal subclinical hypothyroidism on obstetrical outcomes during early pregnancy[J]. Journal of Endocrinological Investigation， 2012， 35(3)：322-325. [27]Maruo T， Matsuo H， Mochizuki M . Thyroid hormone as a biological amplifier of differentiated trophoblast function in early pregnancy[J]. European Journal of Endocrinology， 1991， 125(1)：58-66. [28]Abalovich M， Gutierrez S， Alcaraz G， et al. Overt and subclinical hypothyroidism complicating pregnancy.[J]. Thyroid Official Journal of the American Thyroid Association， 2002， 12(1)：63. [29]Koonings PP . Perinatal outcome in hypothyroid pregnancies.[J]. International Journal of Gynecology & Obstetrics， 1993， 43(2)：349-353. [30]Emmy VDB， Vissenberg R， Land JA， et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy：a systematic review[J]. Human Reproduction Update， 2016：dmw003. [31]Cakmak BD， Turker UA， Temur M， et al. Pregnancy outcomes of antibody negative and untreated subclinical hypothyroidism[J]. J Obstet Gynaecol Res，2019，45(4)， 810-816. [32]Su PY， Huang K， Hao JH， et al. Maternal thyroid function in the first twenty weeks of pregnancy and subsequent fetal and infant development：a prospective populationbased cohort study in china[J]. J Clin Endocrinol Metab，2011，96(10)：3234-3241. [33]Menard MK， Main EK， Currigan SM. Executive summary of the reVITALize initiative：standardizing obstetric data definitions[J]. Obstet Gynecol， 2014， 124：150-153. [34]Say L， Chou D， Gemmill A， et al. Global causes of maternal death：a WHO systematic analysis[J]. Lancet Glob Health， 2014，2：e323-e333.